RASAL2 and posterior cortical atrophy: We provided evidence that RASAL2 may specifically promote the proliferation of PCa cells through the PI3K/AKT/cyclin D1 signalling pathway, which identified RASAL2 as a potential prognostic marker and therapeutic target for PCa.